Answer
Yes. Anthracycline-related heart damage can occur during treatment or months to years later, so cardiac risk and function are assessed.
Sources for this answer
- PHARMORUBICIN — Current selected SmPCemc · Summary of Product Characteristics
- Epirubicin hydrochloride 2 mg/ml solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.